Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
08:24
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

WFH 2016 World Congress

 

24-28 July 2016 Orlando
FAQs
   
Discussion forum - WFH 2016 World Congress
    Topic - Novel therapeutic agents

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 89
Visits: 26
Title: Interaction of BAX 826 (PSAylated rFVIII) with VWF and LRP1 An in vitro and in vivo assessment
Authors: Michael Dockal , A. KopicS. KnappeM. BillweinM. SchaedlerPL TurecekW HoellrieglF ScheiflingerM Dockal
Centre: Shire

You must be registered to reply or comment.

INTERACTION OF BAX 826 (PSAYLATED RFVIII) WITH VWF AND LRP1 AN IN VITRO AND IN VIVO ASSESSMENT

Michael Dockal
Thread initiator
Subspeciality
Reg: 5/9/2016 9:07:00 AM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 7/19/2016 4:28:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions

Poster most viewed in this topic
Poster: 98
Visits: 72
Title: Factor VIIa-CTP , a novel FVIIa potentially supporting subcutaneous treatment - comprehensive assessment in Hemophilic animals models in preparation for first in human study.
Authors: Gili Hart ,
Centre: OPKO Biologics


 






PosterSessionOnline
Logo Draft
 
Logo Cert